Navigation Links
ThermoGenesis Reports Fourth Quarter and Year End 2011 Results; Annual Net Loss Reduced by More Than 50 Percent
Date:9/12/2011

o support our initiatives," he added.

The Company said that it expects revenues for the first two quarters of fiscal 2012 will be relatively consistent with those of the fourth quarter 2011.

Company's Conference Call and WebcastManagement will hold a conference call today at 2 p.m., Pacific (5 p.m., Eastern) to review the fiscal 2011 fourth quarter results.

Conference call details:Dial-in (U.S.):1-800-860-2442Dial-in (Internationally):1-412-858-4600Conference Name:"ThermoGenesis"To listen to the audio webcast of the call during or after the event, please visit

http://www.thermogenesis.com/investors-webcasts-and-calls.aspx

An audio replay of the conference call will be available beginning approximately two hours after completion of the call for the following five business days.

To access the replay:Access number (U.S.):1-877-344-7529Access number (Internationally)1-412-317-0088Conference ID#:385107About ThermoGenesis Corp.ThermoGenesis Corp. (www.thermogenesis.com) is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products. These include:

  • The BioArchive® System, an automated cryogenic device, used by cord blood stem cell banks in more than 30 countries for cryopreserving and archiving cord blood stem cell units for transplant.
  • AXP® AutoXpress™ Platform (AXP), a proprietary family of automated devices that includes the AXP and the MXP™ MarrowXpress™ and companion sterile blood processing disposables for harvesting stem cells in closed systems. The AXP device is used for the processing of cord blood. The MXP is used for the preparation of cell concentrates, including stem cells, from bone marrow aspirates in the laboratory settin
    '/>"/>

  • SOURCE ThermoGenesis Corp.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
    2. ThermoGenesis Announces National Institute of Health Grant
    3. ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program
    4. ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer
    5. ThermoGenesis Announces Reverse Stock Split Effective on NASDAQ Capital Market August 27, 2010
    6. ThermoGenesis Regains Compliance With NASDAQ Listing Rules
    7. ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000
    8. ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement
    9. ThermoGenesis Corp. to Announce First Quarter Fiscal 2011 Results on November 4, 2010
    10. ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
    11. ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... SAN DIEGO , Sept. 2, 2015  MEI ... focused on the clinical development of novel therapies for ... June 30, 2015. Logo - http://photos.prnewswire.com/prnh/20140805/133834 ... the fiscal year, I am quite pleased with how ... Daniel P. Gold , Ph.D., President and Chief ...
    (Date:9/2/2015)... YORK , Sept. 2, 2015 Relmada ... novel therapies for the treatment of chronic pain, announced ... meetings at both the FBR Second Annual Healthcare Conference ... as follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor ...
    (Date:9/2/2015)... Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and ... development and commercialization of new cancer therapies, today ... "A Comparison of the Mechanisms and Cytotoxic ... Tumor Models Harboring Wild-type and Mutant p53," ...
    Breaking Medicine Technology:MEI Pharma Reports Fiscal Year 2015 Results 2MEI Pharma Reports Fiscal Year 2015 Results 3MEI Pharma Reports Fiscal Year 2015 Results 4MEI Pharma Reports Fiscal Year 2015 Results 5MEI Pharma Reports Fiscal Year 2015 Results 6MEI Pharma Reports Fiscal Year 2015 Results 7Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 3DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 4
    ... Limited (ASX: PGL; Nasdaq: PGLA) today provided an ... 3 hepatocellular,carcinoma (HCC, primary liver cancer) study. The ... for patient recruitment, though a thorough,examination of available ... who are able to be enrolled by 31 ...
    ... more than 100% in third quarter, ANN ... in scalable behavior change interventions with outcomes, secured,several ... the third quarter of 2007. The company also ... honored for its,leadership and innovation., HealthMedia,s health ...
    Cached Medicine Technology:Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer 2Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer 3HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 2HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 3
    (Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as Ovarian ... Bright Pink, a national non-profit focused on the prevention and early detection of ... campaign to educate women to be breast and ovarian self-aware and celebrate positive, ...
    (Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Traveling to ... a wide array of magnificent flora and fauna. , Lifestyle Holidays Vacation ... well-preserved history. To help make travelers experience that much better, Lifestyle Holidays Vacation Club ...
    (Date:9/1/2015)... Hills, CA (PRWEB) , ... September 01, 2015 ... ... International Business Times discusses the hundreds of thousands of plastic surgeries conducted each ... media and reality TV for the growing numbers. Beverly Hills-based plastic surgeon Payam ...
    (Date:9/1/2015)... ... , ... September is National Prostate Cancer Awareness Month and Florida Hospital Zephyrhills ... year in the United States. , Prostate cancer is to men what breast cancer ... in 7 men. One new case occurs every 2.3 minutes and a man dies ...
    (Date:9/1/2015)... ... September 01, 2015 , ... The Capillus82™ has ... of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA ... demonstrating its safety when used at home to combat hair loss. , ...
    Breaking Medicine News(10 mins):Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
    ... staff members working in a hospital,s fast-paced emergency department ... involved in medication errors that harm patients, new Johns ... serious issues related to temporary nursing staff in particular ... of the health care workforce owing to the national ...
    ... SUNY Downstate Medical Center have received a $50,000 grant ... develop a diagnostic test for the folate receptor autoantibody. ... cerebral folate deficiency in infants and autism spectrum disorders. ... United States, neural tube defects result in the brain ...
    ... to make people "tear up," but a new study led by ... nasal spray containing an ingredient derived from hot chili peppers ( ... sinus inflammation. The study, which appears in the August ... compares the use of the Capsicum annum nasal spray ...
    ... (HealthDay News) -- Interbreeding between modern humans, Neanderthals and ... boost peoples, immune systems today, researchers report. Modern ... share a common African ancestor, the team of scientists ... Science . However, the groups diverged into separate, distinct ...
    ... hormone receptor guanylyl cyclase C (GCC) has been established ... evidence from Thomas Jefferson University suggests it ... pandemics: obesity. Reporting in the August 25 ... Scott Waldman, M.D., Ph.D., chairman of the ...
    ... , THURSDAY, Aug. 25 (HealthDay News) -- For kids, the end ... sleeping until noon: It also signals the beginning of brand new ... your child is a preschooler or a teen, some anxiety about ... is to know how to ease your children,s stress and manage ...
    Cached Medicine News:Health News:Temporary ER staff poses increased safety risk to patients 2Health News:Temporary ER staff poses increased safety risk to patients 3Health News:Researchers developing new test to measure risk for birth defects and neuro-developmental disorders 2Health News:Thank Neanderthals for That Healthy Immune System, Scientists Say 2Health News:Could a tumor suppressor also fight obesity? 2Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3
    Thesystem combines an exclusive dual light-source design and a versatile sample compartment to provide solid, reliable performance....
    Inquire...
    The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
    The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
    Medicine Products: